Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids
- PMID: 19126247
- PMCID: PMC2811401
- DOI: 10.1017/S0266462309090035
Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids
Abstract
Objectives: The aim of this study is to evaluate the cost-effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) compared with alternative treatments for uterine fibroids in the United States.
Methods: We used techniques of decision analysis and data from secondary sources to develop and estimate an economic model of the management of uterine fibroids among premenopausal women. Patients in the model receive treatment with MRgFUS, uterine artery embolization (UAE), abdominal myomectomy, hysterectomy, or pharmacotherapy. The model predicts total costs (including subsequent procedures) and quality-adjusted life-years (QALYs) for each treatment strategy over a lifetime horizon, discounted at 3 percent, from a societal perspective. Data on treatment efficacy and safety were obtained from published and unpublished studies. Costs (2005 US$) were obtained from an analysis of a large administrative database and other secondary sources. Lost productivity costs were included in the base-case analysis, but excluded in a sensitivity analysis.
Results: UAE was associated with the most QALYs (17.39), followed by MRgFUS (17.36), myomectomy (17.31), hysterectomy (17.18), and pharmacotherapy (16.70). Pharmacotherapy was the least costly strategy ($9,200 per patient), followed by hysterectomy ($19,800), MRgFUS ($27,300), UAE ($28,900), and myomectomy ($35,100). Incremental cost-effectiveness ratios (cost per QALY gained) were $21,800 for hysterectomy, $41,400 for MRgFUS, and $54,200 for UAE; myomectomy was more costly and less effective than both MRgFUS and UAE. Results were sensitive to MRgFUS recurrence rates, MRgFUS procedure costs, and assumptions about quality of life following hysterectomy.
Conclusions: Our findings suggest that MRgFUS is in the range of currently accepted criteria for cost-effectiveness, along with hysterectomy and UAE.
Figures
Similar articles
-
Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.J Comp Eff Res. 2014 Sep;3(5):503-14. doi: 10.2217/cer.14.32. Epub 2014 May 30. J Comp Eff Res. 2014. PMID: 24878319 Free PMC article.
-
Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.Ont Health Technol Assess Ser. 2015 Mar 1;15(5):1-61. eCollection 2015. Ont Health Technol Assess Ser. 2015. PMID: 26357531 Free PMC article.
-
MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis.AJR Am J Roentgenol. 2014 Aug;203(2):361-71. doi: 10.2214/AJR.13.11446. AJR Am J Roentgenol. 2014. PMID: 25055272 Free PMC article.
-
Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy.Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):735-47. doi: 10.1016/j.bpobgyn.2008.01.010. Epub 2008 Mar 7. Best Pract Res Clin Obstet Gynaecol. 2008. PMID: 18328788 Review.
-
Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.Radiology. 2004 Jan;230(1):207-13. doi: 10.1148/radiol.2301021482. Radiology. 2004. PMID: 14695395 Review.
Cited by
-
Spatial and Temporal Control of Hyperthermia Using Real Time Ultrasonic Thermal Strain Imaging with Motion Compensation, Phantom Study.PLoS One. 2015 Aug 5;10(8):e0134938. doi: 10.1371/journal.pone.0134938. eCollection 2015. PLoS One. 2015. PMID: 26244783 Free PMC article.
-
Comparison of (Cost-)Effectiveness of Magnetic Resonance Image-Guided High-Intensity-Focused Ultrasound With Standard (Minimally) Invasive Fibroid Treatments: Protocol for a Multicenter Randomized Controlled Trial (MYCHOICE).JMIR Res Protoc. 2021 Nov 24;10(11):e29467. doi: 10.2196/29467. JMIR Res Protoc. 2021. PMID: 34821569 Free PMC article.
-
Role of magnetic resonance-high intensity focused ultrasound (MR-HIFU) in uterine fibroids management: an updated systematic review and meta-analysis.Wideochir Inne Tech Maloinwazyjne. 2022 Mar;17(1):83-94. doi: 10.5114/wiitm.2021.109760. Epub 2021 Oct 8. Wideochir Inne Tech Maloinwazyjne. 2022. PMID: 35251392 Free PMC article.
-
Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis.PLoS One. 2015 Jun 9;10(6):e0129044. doi: 10.1371/journal.pone.0129044. eCollection 2015. PLoS One. 2015. PMID: 26057930 Free PMC article.
-
Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.J Minim Invasive Gynecol. 2016 Feb 1;23(2):223-33. doi: 10.1016/j.jmig.2015.09.025. Epub 2015 Oct 22. J Minim Invasive Gynecol. 2016. PMID: 26475764 Free PMC article.
References
-
- Agency for Healthcare Research and Quality (AHRQ) Evidence Report No. 34. Management of uterine fibroids volume 1. January 2001http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.47755. Accessed April 5, 2006
-
- American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Surgical alternatives to hysterectomy in the management of leiomyomas. Washington, DC: American College of Obstetricians and Gynecologists; 2000. . Number 16.
-
- Arleo EK, Khilnani NM, Ng A, Min RJ. Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound. J Vasc Interv Radiol. 2007;18:681–685. - PubMed
-
- Beinfeld MT, Bosch JL, Gazelle GS. Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors. Acad Radiol. 2002;9:1300–1304. - PubMed
-
- Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology. 2004;230:207–213. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical